<DOC>
	<DOCNO>NCT01500057</DOCNO>
	<brief_summary>This Phase 4 , prospective , open-label , randomize study Greenlight XPS Laser versus BiVAP Saline Vaporization prostate men symptomatic Benign Prostatic Hyperplasia ( BPH ) . The study consist screen phase , treatment , follow follow-up visit 1 week , 4 week , 3 month , 6 month , 12 month .</brief_summary>
	<brief_title>Phase 4 Study Greenlight XPS Laser Versus BiVAP Saline Vaporization Prostate Men With Symptomatic Benign Prostatic Hyperplasia</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<criteria>male age 18 year present symptomatic/ obstructive symptom secondary PBH require surgical intervention subject must read , understand sign Informed Consent AUA ≥ 15 Qmax &lt; 15mL/sec Stopped BPH medication . Alpha blockers 15 day 5αreductase 3 month Prostate volume ≥ 30g PVR &gt; 300ml Current urine retention Previous surgical invasive treatment ( TURP , TUMT , TUNA ) PSA ≥ 4 ( must negative biopsy within last 12 month ) Neurogenic bladder Obstruction due urethral stricture Any disorder condition subject investigator believe counter indicate inclusion study</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>enlarge prostate</keyword>
</DOC>